Roundtable

Carbon Emissions Disclosure

January 1, 2026

July 2026

We are providing THL’s carbon emissions related to both THL’s portfolio company ownership as well as THL’s operations. We have used the GHG Reporting Protocol to generate this report.

Related content

Press Release

THL Completes Sale of AMI to Lattice Semiconductor

Transaction concludes successful partnership focused on advancing mission-critical firmware for the AI computing era BOSTON – July 25, 2026 – THL Partners (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the successful completion of its sale of AMI, a global leader in firmware and platform management solutions, to Lattice Semiconductor (NASDAQ:

July 27, 2026

Insights

Why We Invested in Celerion: Advancing the Future of Clinical Pharmacology

Key Takeaways: In April 2026, THL announced a majority investment in Celerion, a global leader in clinical pharmacology and bioanalytical sciences that supports pharmaceutical and biotechnology companies in advancing new therapies through critical stages of clinical development. As drug development becomes increasingly complex — driven by novel therapeutic modalities, precision medicine, and evolving regulatory requirements — clinical

Healthcare (HC)

Roundtable

Carbon Emissions Disclosure

Related content

THL Completes Sale of AMI to Lattice Semiconductor

Todd Abbrecht: A “Servant Leader” Finds Meaning and Reward in Private Equity

Why We Invested in Celerion: Advancing the Future of Clinical Pharmacology

Want to learn more?